Last 12 months
Inside the activity.
6 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 21 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 3 |
| Apr 2026 | 2 | 5 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2020 Filed May 20, 2020 23:43 UTC |
Kallenbach CharlesGeneral Counsel & Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0000899243-20-013749 · doc4.xml · derivative · entry 3 Kallenbach Charles · CIK 0001309021 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,285 Underlying: Common Stock · 2,500 shares Expires 2026-10-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of this option vested and became exercisable on October 17, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. Read SEC document |
| May 18, 2020 Filed May 20, 2020 23:43 UTC |
Kallenbach CharlesGeneral Counsel & Secretary
|
SaleCommon Stock | 2,500 | $27.20 | $68,000.00 |
DisclosureSEC source: 0000899243-20-013749 · doc4.xml · nonDerivative · entry 2 Kallenbach Charles · CIK 0001309021 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,150 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 18, 2020 Filed May 20, 2020 23:43 UTC |
Kallenbach CharlesGeneral Counsel & Secretary
|
Exercise / conversionCommon Stock | 2,500 | $2.55 | $6,375.00 |
DisclosureSEC source: 0000899243-20-013749 · doc4.xml · nonDerivative · entry 1 Kallenbach Charles · CIK 0001309021 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:43 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 255 | $26.00 | $6,630.00 |
DisclosureSEC source: 0000899243-20-012584 · doc4.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,276 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 01, 2020 Filed May 5, 2020 00:43 UTC |
Altier ThomasChief Financial Officer
|
SaleCommon Stock | 1,096 | $24.34 | $26,673.79 |
DisclosureSEC source: 0000899243-20-011950 · doc4.xml · nonDerivative · entry 3 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,981 F4 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.82 to $24.63 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 01, 2020 Filed May 5, 2020 00:37 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,474 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000899243-20-011941 · doc4.xml · derivative · entry 6 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,281 Underlying: Common Stock · 13,474 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| May 01, 2020 Filed May 5, 2020 00:37 UTC |
VanDuyn Amy BethSVP, Human Resources
|
SaleCommon Stock | 9,574 | $24.96 | $238,992.89 |
DisclosureSEC source: 0000899243-20-011941 · doc4.xml · nonDerivative · entry 5 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,267 F4 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.82 to $25.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 01, 2020 Filed May 5, 2020 00:37 UTC |
VanDuyn Amy BethSVP, Human Resources
|
SaleCommon Stock | 3,900 | $24.66 | $96,193.11 |
DisclosureSEC source: 0000899243-20-011941 · doc4.xml · nonDerivative · entry 4 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,841 F4 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.82 to $24.81 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 01, 2020 Filed May 5, 2020 00:37 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Exercise / conversionCommon Stock | 13,474 | $2.03 | $27,352.22 |
DisclosureSEC source: 0000899243-20-011941 · doc4.xml · nonDerivative · entry 3 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:43 UTC |
Altier ThomasChief Financial Officer
|
Tax withholdingCommon Stock | 710 | $23.67 | $16,805.70 |
DisclosureSEC source: 0000899243-20-011950 · doc4.xml · nonDerivative · entry 2 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,077 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:43 UTC |
Altier ThomasChief Financial Officer
|
GrantCommon Stock | 1,806 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-011950 · doc4.xml · nonDerivative · entry 1 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,787 F1 · shares: On August 5, 2019, the Reporting Person was granted certain performance-based Restricted Stock Units ("RSUs") under the Phreesia, Inc. 2019 Stock Option and Incentive Plan, the vesting of which was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 1,806 RSUs. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:47 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 3,672 | $23.67 | $86,916.24 |
DisclosureSEC source: 0000899243-20-011952 · doc4.xml · nonDerivative · entry 2 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,101,406 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:47 UTC |
Indig ChaimDirector · Chief Executive Officer
|
GrantCommon Stock | 6,898 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-011952 · doc4.xml · nonDerivative · entry 1 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105,078 F1 · shares: On August 5, 2019, the Reporting Person was granted certain performance-based Restricted Stock Units ("RSUs") under the Phreesia, Inc. 2019 Stock Option and Incentive Plan, the vesting of which was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 6,898 RSUs. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:41 UTC |
Linetsky DavidSVP, Life Sciences
|
Tax withholdingCommon Stock | 786 | $23.67 | $18,604.62 |
DisclosureSEC source: 0000899243-20-011948 · doc4.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,531 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:41 UTC |
Linetsky DavidSVP, Life Sciences
|
GrantCommon Stock | 1,806 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-011948 · doc4.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,317 F1 · shares: On August 5, 2019, the Reporting Person was granted certain performance-based Restricted Stock Units ("RSUs") under the Phreesia, Inc. 2019 Stock Option and Incentive Plan, the vesting of which was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 1,806 RSUs. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:41 UTC |
Kallenbach CharlesGeneral Counsel & Secretary
|
Tax withholdingCommon Stock | 337 | $23.67 | $7,976.79 |
DisclosureSEC source: 0000899243-20-011947 · doc4.xml · nonDerivative · entry 2 Kallenbach Charles · CIK 0001309021 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,150 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:41 UTC |
Kallenbach CharlesGeneral Counsel & Secretary
|
GrantCommon Stock | 1,026 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-011947 · doc4.xml · nonDerivative · entry 1 Kallenbach Charles · CIK 0001309021 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,487 F1 · shares: On August 5, 2019, the Reporting Person was granted certain performance-based Restricted Stock Units ("RSUs") under the Phreesia, Inc. 2019 Stock Option and Incentive Plan, the vesting of which was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 1,026 RSUs. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:40 UTC |
Roberts EvanChief Operating Officer
|
Tax withholdingCommon Stock | 795 | $23.67 | $18,817.65 |
DisclosureSEC source: 0000899243-20-011946 · doc4.xml · nonDerivative · entry 2 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,799 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:40 UTC |
Roberts EvanChief Operating Officer
|
GrantCommon Stock | 1,806 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-011946 · doc4.xml · nonDerivative · entry 1 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714,594 F1 · shares: On August 5, 2019, the Reporting Person was granted certain performance-based Restricted Stock Units ("RSUs") under the Phreesia, Inc. 2019 Stock Option and Incentive Plan, the vesting of which was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 1,806 RSUs. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:38 UTC |
Nathan DanielChief Technology Officer
|
Tax withholdingCommon Stock | 1,470 | $23.67 | $34,794.90 |
DisclosureSEC source: 0000899243-20-011943 · doc4.xml · nonDerivative · entry 2 Nathan Daniel · CIK 0001777126 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,196 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:38 UTC |
Nathan DanielChief Technology Officer
|
GrantCommon Stock | 2,746 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-011943 · doc4.xml · nonDerivative · entry 1 Nathan Daniel · CIK 0001777126 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,666 F1 · shares: On August 5, 2019, the Reporting Person was granted certain performance-based Restricted Stock Units ("RSUs") under the Phreesia, Inc. 2019 Stock Option and Incentive Plan, the vesting of which was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 2,746 RSUs. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:37 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Tax withholdingCommon Stock | 625 | $23.67 | $14,793.75 |
DisclosureSEC source: 0000899243-20-011941 · doc4.xml · nonDerivative · entry 2 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,267 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2020 Filed May 5, 2020 00:37 UTC |
VanDuyn Amy BethSVP, Human Resources
|
GrantCommon Stock | 1,806 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-011941 · doc4.xml · nonDerivative · entry 1 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,892 F1 · shares: On August 5, 2019, the Reporting Person was granted certain performance-based Restricted Stock Units ("RSUs") under the Phreesia, Inc. 2019 Stock Option and Incentive Plan, the vesting of which was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 1,806 RSUs. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 20:44 UTC |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,376 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0000899243-20-011561 · doc4.xml · derivative · entry 3 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,379 Underlying: Common Stock · 1,376 shares Expires 2028-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of this option vested and became exercisable on August 7, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 20:44 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 4,220 | $26.00 | $109,720.00 |
DisclosureSEC source: 0000899243-20-011561 · doc4.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,511 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 20:44 UTC |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionCommon Stock | 1,376 | $4.71 | $6,480.96 |
DisclosureSEC source: 0000899243-20-011561 · doc4.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 27, 2020 Filed Sep 10, 2021 21:16 UTC Amendment |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionStock Options (Right to buy) · Derivative | 1,376 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001562180-21-005906 · primarydocument.xml · derivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,756 Underlying: Common Stock · 1,376 shares Expires 2028-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of this option vested and became exercisable on August 7, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. F2 · balance_after: The original Form 4, filed on April 29, 2020, is being amended by this Form 4 amendment to correct the number of derivative securities beneficially owned by the Reporting Person after the reported transaction. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:48 UTC |
Kallenbach CharlesGeneral Counsel & Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0000899243-20-011344 · doc4.xml · derivative · entry 3 Kallenbach Charles · CIK 0001309021 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,785 Underlying: Common Stock · 5,000 shares Expires 2026-10-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of this option vested and became exercisable on October 17, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:48 UTC |
Kallenbach CharlesGeneral Counsel & Secretary
|
SaleCommon Stock | 5,000 | $25.00 | $125,000.00 |
DisclosureSEC source: 0000899243-20-011344 · doc4.xml · nonDerivative · entry 2 Kallenbach Charles · CIK 0001309021 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,461 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:48 UTC |
Kallenbach CharlesGeneral Counsel & Secretary
|
Exercise / conversionCommon Stock | 5,000 | $2.55 | $12,750.00 |
DisclosureSEC source: 0000899243-20-011344 · doc4.xml · nonDerivative · entry 1 Kallenbach Charles · CIK 0001309021 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 21:24 UTC |
Davidoff Michael J.See Remarks
|
SaleCommon Stock | 4,285 | $20.10 | $86,141.36 |
DisclosureSEC source: 0000899243-20-010670 · doc4.xml · nonDerivative · entry 1 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,314 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 09, 2020 Filed Jun 15, 2020 22:05 UTC Amendment |
Davidoff Michael J.See Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,284 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0000899243-20-016574 · doc4a.xml · derivative · entry 3 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,067 Underlying: Common Stock · 4,284 shares Expires 2029-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The original Form 4, filed on April 13, 2020, is being amended by this Form 4 amendment to reflect the exercise of 4,284 stock options by the Reporting Person on April 9, 2020 that was inadvertently omitted, to correct the number of securities disposed in Table 1, and to correct the number of shares beneficially owned by the Reporting Person after the reported transaction. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 25% of this option vested and became exercisable on January 17, 2020, with the remainder vesting in three (3) equal annual installments thereafter. Read SEC document |
| April 09, 2020 Filed Jun 15, 2020 22:05 UTC Amendment |
Davidoff Michael J.See Remarks
|
SaleCommon Stock | 4,284 | $20.10 | $86,121.25 |
DisclosureSEC source: 0000899243-20-016574 · doc4a.xml · nonDerivative · entry 2 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,003 F1 · kind: The original Form 4, filed on April 13, 2020, is being amended by this Form 4 amendment to reflect the exercise of 4,284 stock options by the Reporting Person on April 9, 2020 that was inadvertently omitted, to correct the number of securities disposed in Table 1, and to correct the number of shares beneficially owned by the Reporting Person after the reported transaction. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs""). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 09, 2020 Filed Jun 15, 2020 22:05 UTC Amendment |
Davidoff Michael J.See Remarks
|
Exercise / conversionCommon Stock | 4,284 | $8.03 | $34,400.52 |
DisclosureSEC source: 0000899243-20-016574 · doc4a.xml · nonDerivative · entry 1 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,287 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The original Form 4, filed on April 13, 2020, is being amended by this Form 4 amendment to reflect the exercise of 4,284 stock options by the Reporting Person on April 9, 2020 that was inadvertently omitted, to correct the number of securities disposed in Table 1, and to correct the number of shares beneficially owned by the Reporting Person after the reported transaction. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs""). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:05 UTC |
Davidoff Michael J.See Remarks
|
SaleCommon Stock | 1,404 | $20.13 | $28,264.49 |
DisclosureSEC source: 0000899243-20-010148 · doc4.xml · nonDerivative · entry 1 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,599 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 01, 2020 Filed Jun 15, 2020 22:02 UTC Amendment |
Davidoff Michael J.See Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,404 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0000899243-20-016571 · doc4a.xml · derivative · entry 3 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,351 Underlying: Common Stock · 1,404 shares Expires 2029-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The original Form 4, filed on April 3, 2020, is being amended by this Form 4 amendment to reflect the exercise of 1,404 stock options by the Reporting Person on April 1, 2020 that was inadvertently omitted, and to correct the number of shares beneficially owned by the Reporting Person after the reported transaction. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 25% of this option vested and became exercisable on January 17, 2020, with the remainder vesting in three (3) equal annual installments thereafter. Read SEC document |
| April 01, 2020 Filed Jun 15, 2020 22:02 UTC Amendment |
Davidoff Michael J.See Remarks
|
SaleCommon Stock | 1,404 | $20.13 | $28,264.49 |
DisclosureSEC source: 0000899243-20-016571 · doc4a.xml · nonDerivative · entry 2 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,003 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs""). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 01, 2020 Filed Jun 15, 2020 22:02 UTC Amendment |
Davidoff Michael J.See Remarks
|
Exercise / conversionCommon Stock | 1,404 | $8.03 | $11,274.12 |
DisclosureSEC source: 0000899243-20-016571 · doc4a.xml · nonDerivative · entry 1 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The original Form 4, filed on April 3, 2020, is being amended by this Form 4 amendment to reflect the exercise of 1,404 stock options by the Reporting Person on April 1, 2020 that was inadvertently omitted, and to correct the number of shares beneficially owned by the Reporting Person after the reported transaction. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs""). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 21:35 UTC |
Davidoff Michael J.See Remarks
|
SaleCommon Stock | 689 | $20.00 | $13,780.00 |
DisclosureSEC source: 0000899243-20-009867 · doc4.xml · nonDerivative · entry 1 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,003 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 20:49 UTC |
Davidoff Michael J.See Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,479 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0000899243-20-009644 · doc4.xml · derivative · entry 5 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,479 shares Expires 2023-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 20:49 UTC |
Davidoff Michael J.See Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,377 | $0.00 Strike: $0.69 | $0.00 |
DisclosureSEC source: 0000899243-20-009644 · doc4.xml · derivative · entry 4 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,377 shares Expires 2022-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 20:49 UTC |
Davidoff Michael J.See Remarks
|
Exercise / conversionCommon Stock | 20,479 | $0.84 | $17,202.36 |
DisclosureSEC source: 0000899243-20-009644 · doc4.xml · nonDerivative · entry 3 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 20:49 UTC |
Davidoff Michael J.See Remarks
|
Exercise / conversionCommon Stock | 11,377 | $0.69 | $7,850.13 |
DisclosureSEC source: 0000899243-20-009644 · doc4.xml · nonDerivative · entry 2 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 20:49 UTC |
Davidoff Michael J.See Remarks
|
SaleCommon Stock | 3,851 | $20.06 | $77,262.23 |
DisclosureSEC source: 0000899243-20-009644 · doc4.xml · nonDerivative · entry 1 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,836 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.01 to $20.155 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 23, 2020 Filed Mar 25, 2020 21:19 UTC |
Davidoff Michael J.See Remarks
|
SaleCommon Stock | 700 | $20.06 | $14,044.52 |
DisclosureSEC source: 0000899243-20-009412 · doc4.xml · nonDerivative · entry 1 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,687 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.04 to $20.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 21:04 UTC |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 43,234 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0000899243-20-008632 · doc4.xml · derivative · entry 6 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 43,234 shares Expires 2023-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 21:04 UTC |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,551 | $0.00 Strike: $0.69 | $0.00 |
DisclosureSEC source: 0000899243-20-008632 · doc4.xml · derivative · entry 5 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,551 shares Expires 2022-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 21:04 UTC |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,275 | $0.00 Strike: $0.82 | $0.00 |
DisclosureSEC source: 0000899243-20-008632 · doc4.xml · derivative · entry 4 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,275 shares Expires 2021-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 21:04 UTC |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionCommon Stock | 43,234 | $0.84 | $36,316.56 |
DisclosureSEC source: 0000899243-20-008632 · doc4.xml · nonDerivative · entry 3 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 21:04 UTC |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionCommon Stock | 4,551 | $0.69 | $3,140.19 |
DisclosureSEC source: 0000899243-20-008632 · doc4.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.